Product NDC: | 42023-121 |
Proprietary Name: | sumatriptan succinate |
Non Proprietary Name: | sumatriptan succinate |
Active Ingredient(s): | 6 mg/.5mL & nbsp; sumatriptan succinate |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42023-121 |
Labeler Name: | JHP Pharmaceuticals LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077871 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090806 |
Package NDC: | 42023-121-05 |
Package Description: | 5 VIAL in 1 CARTON (42023-121-05) > .5 mL in 1 VIAL (42023-121-01) |
NDC Code | 42023-121-05 |
Proprietary Name | sumatriptan succinate |
Package Description | 5 VIAL in 1 CARTON (42023-121-05) > .5 mL in 1 VIAL (42023-121-01) |
Product NDC | 42023-121 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | sumatriptan succinate |
Dosage Form Name | INJECTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20090806 |
Marketing Category Name | ANDA |
Labeler Name | JHP Pharmaceuticals LLC |
Substance Name | SUMATRIPTAN SUCCINATE |
Strength Number | 6 |
Strength Unit | mg/.5mL |
Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |